Solutions, Services, and Social Action. Can Store Design Make a Difference?

Retail is exciting, fast-moving, and filled with opportunity, yet information overload is a constant challenge. Join retail strategist, speaker, and trainer Carol Spieckerman every other Thursday as she navigates past the noise to get to the heart of what really matters in retail. In every episode, Carol harnesses her latest retail trajectories and interviews with industry experts to distill tools, tactics, and takeaways for wherever you play in retail. If you’re ready to cut to the chase, or just want to be inspired about where retail is going next, this show is for you.

 

Brick-and-mortar retail is primed to benefit from pent-up demand in a post-pandemic world. But should transactions be the only end game? Stores can play a powerful role in promoting causes, showcasing solutions and services, and fostering employee engagement, yet realizing the potential requires a shift in priorities.

Carol’s guest is passionate about harnessing the power of design to make a difference. Ian Johnston is the founder and creative director of Quinine, a UK-based integrated research, strategy, and design consultancy specializing in establishing and scaling brickand-mortar concepts for non-retail companies.

In this multi-topic interview, Carol and Ian discuss how placing a higher priority on achieving higher purposes benefits retailers across every channel. The episode wraps up with Ian giving his fresh take on multi-format retail, sustainability’s next act, the limits of localization and other hot topics.

In this interview, you’ll learn:

  • Why brick-and-mortar’s distinctions drive digital success
  • How store design aids retailers’ service expansion aspirations
  • How to balance uniqueness and scale to level-up localization strategies
  • Why virtuous brands will win as store shopping surges

Contact information:

Email: ian@quininedesign.com

LinkedIn: Ian Johnston

Website: www.quininedesign.com

Current article: The Unbearable Sense of Shopping: Neurodiversity in Retail

Listen to Previous Episodes Right Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More